Apple Wins Defense Verdict After $506M Optis LTE Trial

A Texas jury rejected Optis’ 4G LTE patent infringement claims against Apple after prior $506 million and $300 million awards were overturned.

ByZach Barreto

Published on

Apple Wins Defense Verdict After $506M Optis LTE Trial

Apple secured a defense verdict in a patent dispute brought by Optis Wireless, a Texas-based intellectual-property management company that accused Apple of infringing patents tied to the 4G LTE wireless standard. The result marks a significant turn in a case that has produced two substantial jury awards against Apple in prior trials, both later set aside on appeal. The litigation has also drawn attention for its overlap with separate proceedings abroad, including a sizable U.K. damages award currently headed to further review. The latest verdict narrows Optis’ leverage in the U.S. forum while leaving related international questions unresolved.

Defense Verdict After Years of Patent Litigation

A jury in Marshall, Texas, found for Apple, rejecting Optis’ claims that iPhones and other Apple devices infringed Optis’ asserted 4G LTE-related patents. Apple has consistently denied infringement and has also challenged the asserted patents as invalid, framing the dispute as an attempt to obtain outsized royalties from standard-essential or standard-adjacent technology.

Following the verdict, an Apple spokesperson stated, “We thank the jury for their time, and we’re pleased they rejected Optis’ false claims,” and characterized Optis’ business model as litigation-focused rather than product-based. Optis did not immediately provide a public response to the outcome. The defense verdict is notable because it arrives after multiple prior U.S. trials and appellate interventions, underscoring how verdict framing and remedies questions can be dispositive in complex patent disputes involving standardized wireless technologies.

Prior Damages Awards Overturned on Procedure and FRAND Concerns

Optis and affiliated entities filed suit in 2019, alleging Apple products practiced patented technology associated with the 4G LTE standard. In 2020, a jury returned a $506 million award for Optis, but U.S. District Judge Rodney Gilstrap later ordered a new trial on damages in 2021. The court concluded the award may not have reflected Optis’ obligation to license the patents on fair and reasonable terms, a recurring issue in disputes involving technology incorporated into widely adopted standards.

A retrial later in 2021 produced a reduced $300 million verdict for Optis. That award also did not survive appellate scrutiny. In 2025, the U.S. Court of Appeals for the Federal Circuit overturned the verdict, finding that the verdict form was improperly structured because it bundled multiple patents into a single infringement question. That procedural defect, rather than a merits determination on infringement or validity, reset the dispute and set the stage for the defense win. Apple is represented by WilmerHale, according to court filings.

Cross-Border Stakes Remain Despite the U.S. Outcome

While the U.S. jury’s decision limits Optis’ recovery in the Texas action, parallel proceedings in the United Kingdom remain consequential for both sides. A U.K. court ruled last year that Apple owes Optis approximately $502 million for infringing Optis’ U.K. wireless patents, reflecting a separate assessment of the parties’ rights and remedies under U.K. patent law and any applicable licensing framework.

Apple is scheduled to pursue an appeal before the U.K. Supreme Court in June. The divergence between the U.S. jury outcome and the U.K. damages ruling illustrates how patent portfolios and licensing disputes can produce materially different results across jurisdictions even when anchored to similar wireless standards. In practical terms, the most immediate implications are procedural and strategic: the U.S. defense verdict reduces near-term domestic exposure, while the U.K. appeal will help determine whether Optis can maintain significant leverage through an overseas judgment.


About the author

Zach Barreto

Zach Barreto

Zach Barreto is a distinguished professional in the legal industry, currently serving as the Senior Vice President of Research at the Expert Institute. With a deep understanding of a broad range of legal practice areas, Zach's expertise encompasses personal injury, medical malpractice, mass torts, and defective products. His skills are particularly evident in handling complex litigation matters, including high-profile cases such as opioids litigation, NFL concussion litigation, California wildfires, 3M earplugs, Elmiron, transvaginal mesh, Roundup, Camp Lejeune, hernia mesh, IVC filters, Paraquat, Paragard, talcum powder, and Zantac.

Under his leadership, the Expert Institute’s research team has expanded impressively from a single member to a robust team of 100 professionals over the last decade. This growth reflects his ability to navigate the intricate and demanding landscape of legal research and expert recruitment effectively. Zach has been instrumental in working on nationally significant litigation matters, including cases involving pharmaceuticals, medical devices, toxic chemical exposure, and wrongful death, among others.

At the Expert Institute, Zach is responsible for managing all aspects of the research department and developing strategic institutional relationships. He plays a key role in equipping attorneys for success through expert consulting, case management, strategic research, and expert due diligence provided by the Institute’s cloud-based legal services platform, Expert iQ. Zach holds a Bachelor's Degree in Political Science and European History from Vanderbilt University.

background image

Subscribe to our newsletter

Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.